Naumed® - medical research & development email format

Naumed Ltd. is a medical research and development company, with a portfolio of innovative, globally patented medical devices, addressing upper and lower respiratory system's conditions. Upper Respiratory igmorino® is the first device globally to painlessly introduce any solution chosen into the paranasal sinuses (maxillary, ethmoid, frontal), even when those are inflame or un-operated. Something that up to now was only achieved through surgery. igmorino® changes that and redefines the treatment of sinus conditions. Low Respiratory "ANASSA" is the first warm mist nebuliser that delivers nebula close to patients' body temperature, without exceeding 50°C in the solution container to prevent degradation of any active/pharmaceutical substances. Compared to existing nebulisers, "ANASSA" medical device excels for the following reasons: 1. vasoconstriction, resulting in reduced absorption of the pharmaceutical substance, increased viscosity of secretions by the inhalation of cold mist nebulisers are avoided as it provides mist at a temperature equal to or higher than the mucosa's temperature. 2. It is well-known that when inhaled air (mist) is at a high temperature, the body's thermoregulatory system is stimulated, causing sweating from both the skin's sweat glands and the epithelial cells of the respiratory system's mucosa. This results in: a) Liquefaction of secretions, facilitating easier expectoration. b) Vasodilation, which enhances the absorption of the active chemical substance. 3. An additional advantage of the "ANASSA" nebulizer lies in its ability to provide warm mist from therapeutic herbal infusions, with known beneficial effects both as an aid in recovery and as a preventive measure against respiratory diseases, as human tradition suggests.